/Lists

Biotech Investors & VC Firms in North America

1593 firms in this list, with a median first check of $500K. 347 of them lead rounds. Generated from verified public data and updated continuously.

Alloy Partners
Indianapolis
18 people
Essex Woodlands Healthcare Partners
New YorkGrowth–Late Stage$20M – $80M
18 people
E2MC Ventures
OrlandoPre-Seed–Late Stage$250K – $2M
16 people
Spring Activator
VancouverPre-Seed–Seed
31 people
WRF Capital
SeattlePre-Seed–Series A$100K – $2M
22 people
OVNI Capital
San FranciscoPre-Seed–Series A$250K – $2M
11 people
Slater Technology Fund
ProvidencePre-Seed–Series A
17 people
Circadian Ventures
AtlantaSeed–Series A$500K – $1.5M
13 people
OSF Ventures
PeoriaSeed–Series A
19 people
Pivotal Life Sciences
San FranciscoPre-Seed–Late Stage
15 people
Ripple Ventures
TorontoPre-Seed–Series A$250K – $1M
15 people
THL FUND
BostonGrowth
24 people
Owl Rock Capital
New YorkGrowth–Late Stage$20M – $250M
20 people
Elad Gil
San FranciscoSeed–Growth$100K – $10M
1 person
Cantos Ventures
San FranciscoPre-Seed–Series B$400K – $1.5M
6 people
Cowtown Angels
Fort WorthPre-Seed–Series A
12 people
MEDA Angels
ArlingtonSeed–Series A$130K – $350K
18 people
Cure Ventures
BostonPre-Seed–Series A
22 people
Dellin Investments
PhiladelphiaPre-Seed–Growth
7 people
Ajax Health
Menlo ParkSeed–Late Stage
27 people
Side Door Ventures
Fernandina BeachPre-Seed–Series B$300K – $5M
18 people
Social Impact Capital
New YorkPre-Seed–Series A$100K – $1.5M
20 people
Avila
Golden BeachSeed–Series A$500K – $2.5M
19 people
Stray Dog Capital
LeawoodPre-Seed–Series A$100K – $1M
7 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.